OUR PRODUCTS

MOBILE APPS

GENERAL INFO

PHVS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Pharvaris (PHVS) Earnings Date & Reports

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PHVS is expected to report earnings to fall 2.65% to -80 cents per share on November 05

Q3'25

Est.

$-0.81

Q2'25

Missed

by $0.06

Q1'25

Missed

by $0.12

Q4'24

Beat

by $0.08

Q3'24

Missed

by $0.18

The last earnings report on August 12 showed earnings per share of -82 cents, missing the estimate of -76 cents. With 167.40K shares outstanding, the current market capitalization sits at 1.43B.

View a ticker or compare two or three

Compare

PHVS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PHVS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PHVS showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Emmy Noetherweg 2

Phone

+31 712036410

Employees

Web

https://www.pharvaris.com